Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0788 USD | +2.34% | +8.69% | -61.37% |
Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 14.8M | Sales 2025 * | 19.28M | Capitalization | 2.78M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | - | EV / Sales 2024 * | 0.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
3.08
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on NovaBay Pharmaceuticals
1 day | +2.34% | ||
1 week | +8.69% | ||
Current month | -24.74% | ||
1 month | -29.14% | ||
3 months | -56.17% | ||
6 months | -77.28% | ||
Current year | -61.37% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.077 | -0.39% | 528,596 |
24-04-24 | 0.0773 | +0.39% | 1,017,592 |
24-04-23 | 0.077 | +6.21% | 1,571,117 |
24-04-22 | 0.0725 | -12.01% | 4,146,227 |
24-04-19 | 0.0824 | -1.90% | 1,715,039 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- NBY Stock